SCENIC international consensus statement on surveillance and management of dysplasia in inflammatory bowel disease

Laine, Loren; Kaltenbach, Tonya; Barkun, Alan N.; McQuaid, Kenneth R.; Subramanian, Venkataraman; Soetikno, Roy; East, James E.; Farraye, Francis A.; Feagan, Brian G.; Ioannidis, John P. A.; Kießlich, Ralf; Krier, Michael J.; Matsumoto, Takayuki; McCabe, Robert P.; Mönkemüller, Klaus; Odze, Robert D.; Picco, M.F.; Rubin, David T.; Rubin, Michele; Rubio, Carlos A.; Rutter, Matthew D.; Sánchez-Yagüe, Andrés; Sanduleanu, Silvia; Shergill, Amandeep K.; Ullman, Thomas; Velayos, Fernando; Yakich, Douglas; Yang, Yu‐Xiao

doi:10.1016/j.gie.2014.12.009

Cited by 416 publications

(663 citation statements)

References 68 publications

Supporting

Mentioning

636

Contrasting

Unclassified

Order By: Relevance

“…Van den Broek and colleagues, for example, detected only 9% of dysplasia using the random biopsy technique [19]. Moreover, in a pooled analysis of 48,522 random biopsies from 1635 patients a mere 45 (0.09%) showed dysplasia [4,5].…”

Section: Crc Surveillance In Ibdmentioning

confidence: 99%

“…Should our surveillance practice identify the many with targeted or the few with random biopsies? A systematic review of studies in the video-endoscopic era revealed that among IBD patients with dysplasia, the dysplasia is visible in approximately 80% of patients examined with standard-definition colonoscopy and in approximately 90% of patients examined with high-definition white-light colonoscopy or chromoendoscopy [4,5].…”

Section: Crc Surveillance In Ibdmentioning

confidence: 99%

“…The recently developed SCENIC international consensus statement offers rigorous evidence based guidance on appropriate surveillance and management of dysplasia in IBD [4,5]. Based on moderate quality of evidence, it concluded that chromoendoscopy is the preferred method for the detection of dysplasia in IBD.…”

Section: Scenic Guidelinesmentioning

confidence: 99%

“…Timely attendance for surveillance is a particular issue; with studies suggesting up to 50% of patients do not attend scheduled surveillance [3]. Equipment and tools, such as high definition systems and enhanced imaging tools, such as contrast dyes, influence the yield of dysplasia detection in surveillance [4].…”

Section: Introductionmentioning

confidence: 99%

“…In this review, we will focus on the SCENIC (Surveillance for Colorectal Endoscopic Neoplasia Detection and Management in IBD Patients International Consensus Recommendations) consensus proposed evidence-based statements for the surveillance and management of dysplasia in IBD [4,5]. We will present the approach to CRC surveillance in patients with IBD, including the chromoendoscopy technique with targeted biopsy.…”

Section: Introductionmentioning

confidence: 99%

See 4 more Smart Citations

Surveillance of patients with inflammatory bowel disease

East

Kaltenbach

2016

Best Practice & Research Clinical Gastroenterology

Self Cite

View full text Add to dashboard Cite

Patients with inflammatory bowel disease involving the colon are at increased risk for developing colorectal cancer. Colonoscopy surveillance is important to identify and treat IBD associated dysplasia. The SCENIC consensus provides evidence-based recommendations for optimal surveillance and management of dysplasia in IBD. Chromoendoscopy, with the surface application of dyes to enhance mucosal visualization, is the superior endoscopic surveillance strategy to detect dysplasia. Most dysplasia is visible, and can be endoscopically resected. Future studies should determine the effect of new surveillance strategies on the incidence of CRC and mortality in patients with IBD.

show abstract

Section: Crc Surveillance In Ibdmentioning

confidence: 99%

Section: Crc Surveillance In Ibdmentioning

confidence: 99%

Section: Scenic Guidelinesmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 3 more Smart Citations